Cargando…
RNA interference targeting Aurora-A sensitizes glioblastoma cells to temozolomide chemotherapy
Clinically, temozolomide (TMZ) is widely used in glioblastoma (GBM) treatment. However, the toxicity of TMZ may influence the quality of patient life. Thus, novel treatment options for sensitizing GBM cells to TMZ chemotherapy are necessary. Aurora-A is widely expressed in GBM and correlated with po...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228570/ https://www.ncbi.nlm.nih.gov/pubmed/28105161 http://dx.doi.org/10.3892/ol.2016.5261 |